Page 3 - Ivan Tornos News Today

Spine and orthopedic devicemakers are ramping up their robotics efforts and have ambitious plans for the year ahead.

The leadership change at Johnson & Johnson MedTech will go down as the year's biggest personnel move in medtech, barring a December surprise.

With a new CEO at the helm, Zimmer Biomet has had a strong year. Heres what to know going into 2024.

The last few years have been tough on spine device companies, but with innovation and value-based care initiatives, opportunities for advancement remain. Learn

Medical device manufacturer Zimmer Biomet is keeping a close eye on the rapid shift of orthopedic and joint replacement cases to the ASC setting.  

Operator: Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet’s Third Quarter 2023 Earnings Conference Call.

Third quarter net sales of $1.754 billion increased 5.0% and 4.7% on a constant currency1 basisThird quarter diluted earnings per share were $0.77; adjusted1 diluted earnings per share were $1.65The...

Zimmer Biomet shares fell today on third-quarter results that came in ahead of the consensus forecast.

The baby-boom generation changes every aspect of life it steamrolls through. Now it’s doing the same to healthcare.

Here are some of the stocks and sectors that are likely to see the biggest impact from the boom in demand for weight-loss drugs. Read on.